This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (30)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Multiple Sclerosis/ Demyelinating Disease  • Alert me on articles by topic  Social Bookmarking   What's this?

Roberto Álvarez-Lafuente, MD; Virginia De las Heras, PhD; Manuel Bartolomé, PhD; Juan José Picazo, MD; Rafael Arroyo, MD

Arch Neurol. 2004;61:1523-1527.

Background  Recent studies have focused on the relationship between human herpesvirus 6 (HHV-6) and multiple sclerosis (MS).

Objective  To analyze HHV-6 messenger RNA expression in patients with relapsing-remitting (RR) MS vs healthy blood donors (HBDs).

Design  One hundred fifty-four subjects were enrolled in the study: 105 patients with RRMS (32 in relapse) and 49 HBDs. Total DNA and messenger RNA were extracted from serum and blood samples, respectively, and analyzed by quantitative real-time reverse transcription0dash;polymerase chain reaction for the detection of 3 HHV-6 immediate-early genes (U16/U17,U89/U90, and U94) and both HHV-6 variants (HHV-6A and HHV-6B).

Results  Active HHV-6 infection was detected in 16% of patients with RRMS vs 0% of HBDs (P = .003). Seven patients with RRMS with exacerbation had HHV-6 active replication, and the virus remained latent in only 1 of them. We did not find any statistically significant difference between HHV-6 active or latent infection for patients in remission (P = .12). Among patients with RRMS with HHV-6 active replication, viral load was higher when they experienced an acute attack than when in remission (P = .04). In those patients with RRMS who had an active infection only, HHV-6A was found. Cell-free HHV-6 DNA detected in serum samples confirmed the results.

Conclusions  The results show that a subset of patients with RRMS experience HHV-6 active infection, and there likely is an association between the viral active replication and relapses; therefore, HHV-6 active infection may imply a greater risk of exacerbations in a subgroup of patients with RRMS.

Author Affiliations: Servicio de Neurología (Drs Álvarez-Lafuente, De las Heras, Bartolomé, and Arroyo) and Servicio de Microbiología Clínica (Dr Picazo), Hospital Clínico San Carlos, Madrid, Spain.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Human herpes virus 6 and multiple sclerosis: a Finnish twin study
Kuusisto et al.
Mult Scler 2008;14:54-58.
ABSTRACT  

Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not Human herpesvirus 6
Mameli et al.
J. Gen. Virol. 2007;88:264-274.
ABSTRACT | FULL TEXT  

Demyelinating diseases.
Love
J. Clin. Pathol. 2006;59:1151-1159.
ABSTRACT | FULL TEXT  

Identification and Characterization of U83A Viral Chemokine, a Broad and Potent {beta}-Chemokine Agonist for Human CCRs with Unique Selectivity and Inhibition by Spliced Isoform
Dewin et al.
J. Immunol. 2006;176:544-556.
ABSTRACT | FULL TEXT  

Balo's concentric sclerosis associated with primary human herpesvirus 6 infection
Pohl et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:1723-1725.
ABSTRACT | FULL TEXT  

TLR Signaling Tailors Innate Immune Responses in Human Microglia and Astrocytes
Jack et al.
J. Immunol. 2005;175:4320-4330.
ABSTRACT | FULL TEXT  

Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter
Opsahl and Kennedy
Brain 2005;128:516-527.
ABSTRACT | FULL TEXT  

Viral Pathogens in Multiple Sclerosis: An Intriguing (Hi)story
Stuve et al.
Arch Neurol 2004;61:1500-1502.
FULL TEXT